Related Experiment Video
Updated: Jul 23, 2025
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.2K
Inflammatory bowel disease: recent developments.
James John Ashton1,2, R Mark Beattie3
1Department of Paediatric Gastroenterology, Southampton Children's Hospital, Southampton, UK.
Archives of Disease in Childhood
|July 19, 2023
Summary
Pediatric inflammatory bowel disease (IBD) is rising in children, with new diagnostic tools and advanced therapies like biologics. Personalized treatment strategies are key for managing this complex condition in young patients.
Area of Science:
- Pediatric Gastroenterology
- Immunology
- Internal Medicine
Background:
- Pediatric-onset inflammatory bowel disease (IBD) incidence has doubled in 25 years, with increasing prevalence and severity.
- Diagnostic tools for IBD in children have advanced, including fecal calprotectin, small bowel imaging, and capsule endoscopy.
- Management options have expanded, incorporating novel targeted therapies and improved drug monitoring.
Purpose of the Study:
- To summarize recent advancements in the diagnosis, investigation, and management of pediatric IBD.
- To highlight the evolving landscape of IBD care for children and young people.
- To discuss the future of personalized and stratified treatment approaches.
Main Methods:
- Review of recent literature on pediatric IBD diagnosis and management.
- Analysis of advancements in diagnostic technologies.
- Evaluation of emerging therapeutic strategies and monitoring techniques.
Main Results:
- Improved diagnostic accuracy with tools like fecal calprotectin and advanced imaging.
- Introduction of targeted therapies (e.g., anti-IL-12/23, JAK-STAT inhibitors) and refined monitoring of established treatments.
- Recognition of IBD as a disease continuum with diverse phenotypes.
Conclusions:
- Recent developments offer improved diagnostic and management options for pediatric IBD.
- Personalized and stratified treatment strategies, utilizing biomarkers, are crucial for future care.
- Multidisciplinary collaboration within clinical networks is essential for optimal outcomes in pediatric IBD.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
154
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
154
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
356
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
356
01:30Inflammatory Bowel Disease II: Crohn's Disease
296
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
296
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
220
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
220
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
174
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
174
01:21Inflammatory Bowel Disease V: Surgical Management
171
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
171